Journal
DNA REPAIR
Volume 31, Issue -, Pages 19-28Publisher
ELSEVIER
DOI: 10.1016/j.dnarep.2015.04.002
Keywords
Nucleotide Excision Repair; Interstrand Crosslink Repair; DNA repair inhibitor; ERCC1-XPF; FANCQ; Melanoma; Ovarian cancer
Categories
Funding
- Cancer Research UK
- MRC Technology Development Gap Fund [A853-0118]
- University of Edinburgh
- MRC [MC_G1000806] Funding Source: UKRI
- Medical Research Council [MC_G1000806] Funding Source: researchfish
Ask authors/readers for more resources
ERCC1-XPF is a structure-specific endonuclease that is required for the repair of DNA lesions, generated by the widely used platinum-containing cancer chemotherapeutics such as cisplatin, through the Nucleotide Excision Repair and Interstrand Crosslink Repair pathways. Based on mouse xenograft experiments, where ERCC1-deficient melanomas were cured by cisplatin therapy, we proposed that inhibition of ERCC1-XPF could enhance the effectiveness of platinum-based chemotherapy. Here we report the identification and properties of inhibitors against two key targets on ERCC1-XPF. By targeting the ERCC1-XPF interaction domain we proposed that inhibition would disrupt the ERCC1-XPF heterodimer resulting in destabilisation of both proteins. Using in silica screening, we identified an inhibitor that bound to ERCC1-XPF in a biophysical assay, reduced the level of ERCC1-XPF complexes in ovarian cancer cells, inhibited Nucleotide Excision Repair and sensitised melanoma cells to cisplatin. We also utilised high throughput and in silica screening to identify the first reported inhibitors of the other key target, the XPF endonuclease domain. We demonstrate that two of these compounds display specificity in vitro for ERCC1-XPF over two other endonucleases, bind to ERCC1-XPF, inhibit Nucleotide Excision Repair in two independent assays and specifically sensitise Nucleotide Excision Repair-proficient, but not Nucleotide Excision Repair-deficient human and mouse cells to cisplatin. (C) 2015 Elsevier BA/. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available